CA-EBD-GROUP
Forward-thinking industry executives converged upon Beijing last week for ChinaBio® Partnering Forum , China’s premier life science partnering event. Senior executives representing leading drug development and medtech companies from around the world attended the event, in search of opportunities to partner in China.
The fifth annual event, held at the Shangri-La Hotel Beijing, was attended by over 750 life science delegates from 405 companies and 22 countries who engaged in more than 1,100 one-to-one meetings facilitated by partneringONE®. Sixty-five percent of attending companies were from China.
ChinaBio® Partnering Forum is co-organized by EBD Group , the premier partnering conference firm for the life science industry, and ChinaBio® LLC, a leading consulting firm in Shanghai.
“As China’s role in the global pharma market continues to increase each year, ChinaBio® Partnering Forum also grows in importance,” said Greg B. Scott , President and Founder of ChinaBio® LLC. “This year, we saw more attendees from both global pharma and China’s leading pharma and biotechs than ever before. Attendees tell us that the Partnering Forum is the best organized and most productive partnering conference in China, and when they are happy, we are happy.”
“The biopharma market in China is a growth market that has more than doubled over the last five years in terms of cross-border collaborations,” said Carola Schropp , President of EBD Group. “Western drug giants and investors are eager to capitalize on the vast potential for in-licensing and distribution partnership deals available at ChinaBio® Partnering Forum. It is a dynamic environment and a high-quality research and manufacturing destination, and this is the impetus for the event.”
Multinational companies including Abbott, AstraZeneca, Bayer, Boehringer Ingelheim, Janssen, Life Technologies, Lonza, Lundbeck, Merck, Novo Nordisk, Qiagen and Sanofi, as well as many others were well represented at the Partnering Forum. China pharma were also strongly represented by 3SBio, BeiGene, BGI, Furen, Fosun, Grand Pharma, Hengrui, Humanwell, Minhaj, Luqa, RuiYi, Reyoung, Sine, SinoPharm, SL Pharma, Tasly and many others.
The main program was focused on global partnering in China, with speakers representing the broad range of industry executives, from leading Chinese companies and service providers to global pharma. This year’s keynote, “Partnering landscape in China: Joining the global game,” was a highlight of the event, and featured executive panelists Eckhard Ottow, MD, PhD from Bayer Pharma AG; Yongkui Sun ,PhD from MSD R&D (China) Co., Ltd.; Jinzi J. Wu, PhD from Ascletis, Inc.; and Steve Yang, PhD from AstraZeneca.
Other panels of high interest were “Biologics and biosimilars in China: The race is on,” “Clinical strategies in China: Smoothing a rough road” and “VC investment: The global connection.”
Video coverage of ChinaBio® Partnering Forum 2013 is available at www.partnering360.com/insight .
The next edition of ChinaBio® Partnering Forum will be held in Suzhou, China, May 7–8, 2014 . The annual event attracts biotech and pharma leaders from around the world and engages delegates with one-to-one meetings, workshops and panels, exhibits, networking receptions and a gala banquet evening event. For more information, please go to www.ebdgroup.com/cbpf .
About EBD Group
EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group’s partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success.
EBD Group’s conferences are run with the support of leading corporations and international trade associations and include:
- BIO-Europe ® and BIO-Europe Spring ®, Europe’s largest life science partnering conferences, supported by the Biotechnology Industry Organization (BIO)
- BioPharm America ™, the fastest growing partnering event in North America
- Biotech Showcase ™, a unique forum in San Francisco for presenting to investors and business development executives, co-produced with Demy-Colton Life Science Advisors
- BioEquity Europe , the investor conference co-organized with BioCentury Publications and BIO
- ChinaBio® Partnering Forum , the first dedicated biotech/pharma partnering conference in China, co-produced with ChinaBio® LLC
- EuroMedtech ™, EBD Group’s partnering event for the innovative medical technology industry
- Partnering for Global Impact ®, a new partnering conference providing an innovative forum to partner, identify and generate social and philanthropic investment and funding opportunities
EBD Group’s sophisticated web-based partnering service, partneringONE® , is used as the partnering engine at numerous third-party events around the world, and partnering360® is the open online community of life science dealmakers that enhances partnering experiences throughout the year.
EBD Group has offices in the USA and Europe.
For more information please visit www.ebdgroup.com .
Additional links and information:
Follow EBD Group on Twitter: twitter.com/ebdgroup
More information is available at www.ebdgroup.com .
About ChinaBio® LLC
ChinaBio® LLC is a boutique consulting and advisory firm focused exclusively on China’s life science industry. Based in Shanghai, ChinaBio works with western companies to help them achieve success in China through partnerships. ChinaBio has identified over 400 licensing and acquisition opportunities in China and helped companies raise over $500 million in funding.
- Consulting: ChinaBio works with western life science companies to implement a successful China strategy and launch their businesses and products in China.
- Advisory: ChinaBio helps western companies secure partnerships and acquisitions and access private and government funding in China.
- Conferences: ChinaBio has organized over 30 life science investment and partnering conferences in China, bringing together companies from around the world.
- Publishing: ChinaBio® Today is the most widely read newsletter on China's life science industry, with over 18,000 readers.
Follow ChinaBio on Twitter at www.twitter.com/ChinaBio .
More information is available at www.chinabiollc.com .
Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20130605006249/en/
Contact:
EBD Group, Inc.
Erin Righetti
+1 760 930 0500
erighetti@ebdgroup.com
or
ChinaBio®
LLC
Jean Meng
From China: +86 21 5137 0751
From US: +1
858 926 4566
jmeng@chinabiollc.com
Link:
Information om Business Wire
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
PPG celebrates 3,000th installation of PPG MOONWALK paint mixing system at U.S. collision center14.8.2025 20:01:00 CEST | Press release
PPG (NYSE: PPG) today announced that it has completed the 3,000th global installation of its PPG MOONWALK® automated paint mixing system at Wren’s Collision Group’s facility in Auburn, Ala. Since its launch in 2019, the PPG MoonWalk system has transformed body shop operations worldwide by delivering exceptional accuracy, traceability and productivity across the automotive repair process. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250814323910/en/ “We are proud to be a part of this innovation in the automotive industry with the installation of the 3,000th PPG MoonWalk system at our newest body shop,” said James Wren, owner of Wren’s Collision Group, at a celebration of the milestone held in July. “With our new Auburn facility, we are looking forward to continuing to drive productivity, efficiency, and profit throughout the 19 body shops we own. We are excited to be a part of this milestone for PPG as a long-standing partn
Xsolla Expands Payment Coverage in Europe to Unlock New Market Potential for Game Developers With Bizum, Swish, and Satispay14.8.2025 18:00:00 CEST | Press release
New Payment Methods Give Game Developers Localized, Mobile-First Checkout Options In Spain, Sweden, And Italy Xsolla, a global commerce company helping developers launch, grow and monetize their games, announces today the expansion of its payments solution across Europe with the launch of new regionally preferred methods: Bizum in Spain, Swish in Sweden, and Satispay in Italy. These integrations via Xsolla Pay Station enable game developers and publishers to offer secure, seamless, and familiar checkout flows across three of the region’s fastest-growing digital economies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250814474025/en/ (Graphic: Xsolla) The European gaming market is expected to generate nearly $85 billion in 2025 and grow to over $112 billion by 2029. As mobile and app-native payment preferences continue to rise globally, players are increasingly demanding fast, secure, and culturally aligned payment options.
Eurazeo Enters Into Exclusive Discussions With INSPIRED PET NUTRITION Regarding the Sale of Its Stake in Ultra Premium Direct14.8.2025 17:40:00 CEST | Press release
Eurazeo has entered into exclusive discussions with INSPIRED PET NUTRITION (“IPN”), the fast-growing international pet food company controlled by CapVest Partners LLP (“CapVest”), regarding the sale of Ultra Premium Direct (“UPD”), France’s leading direct-to-consumer (D2C) online pet food company. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250814809542/en/ Ultra Premium Direct product Founded in 2013, UPD has established itself as a leading player in the French premium pet food market and is now recognised as the top direct-to-consumer (D2C) online brand in the segment, recognised for its exceptional customer experience and already serving over 285k active customers. UPD combines high-quality, veterinarian-developed products with a direct factory-to-consumer model, offering a unique premium yet affordable proposition. Leveraging its data-driven approach, the company is now building a powerful omnichannel strategy to furt
Tyk Scales up in US Financial Sector, as Banks Lean on APIs as Revenue-Driving Infrastructure14.8.2025 17:24:00 CEST | Press release
AI-ready API management company Tyk has announced the appointment of three new senior leaders, as it strengthens its support for banks in the US financial sector. The strategic appointments come as banks increasingly evolve their use of APIs towards monetization. Martin Buhr, Founder and CEO of Tyk, which specializes in providing practical blueprints for integrating AI in a way that’s well-governed, efficient, and future-ready, explains: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250814736978/en/ Tyk scales up in US financial sector “Just a couple of years ago, banks were coming to us focused on basic authentication and control requests. Now, it’s becoming the norm for them to use APIs to underpin new monetization strategies, as well as seamless regulatory compliance. We’ve helped leading global banks make the change and are excited to have three API industry veterans – Mark Gurvis, Laura Heritage and Kuldeepak Angrish –
LambdaTest Unveils Media Injection for Real Device Testing14.8.2025 17:00:00 CEST | Press release
Innovative camera simulation feature enables robust testing of image and video capture workflows across 10,000+ real mobile devices LambdaTest, a unified agentic AI and cloud engineering platform, has launched Video Injection capability in Media Injection for real device testing, bringing powerful support for testing camera and video-based app functionalities at scale. This new capability empowers developers and QA teams to simulate image and video capture scenarios on real Android and iOS devices, unlocking comprehensive validation for camera-driven app experiences. With Media Injection, users can test key workflows like QR code and barcode scanning, digital check processing, real-time video streaming, and photo or video upload features, directly on physical devices. This is made possible through LambdaTest’s proprietary Sensor Instrumentation technology, which seamlessly injects simulated media into the app’s camera interface, bypassing the need for physical camera use while ensuring
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.
Besøg vores nyhedsrum